|
1
|
Mehedintu C, Plotogea MN, Ionescu S and
Antonovici M: Endometriosis still a challenge. J Med Life.
7:349–357. 2014.PubMed/NCBI
|
|
2
|
Scheerer C, Bauer P, Chiantera V, Sehouli
J, Kaufmann A and Mechsner S: Characterization of
endometriosis-associated immune cell infiltrates (EMaICI). Arch
Gynecol Obstet. 294:657–664. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bacci M, Capobianco A, Monno A, Cottone L,
Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S,
et al: Macrophages are alternatively activated in patients with
endometriosis and required for growth and vascularization of
lesions in a mouse model of disease. Am J Pathol. 175:547–556.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ahn SH, Edwards AK, Singh SS, Young SL,
Lessey BA and Tayade C: IL-17A contributes to the pathogenesis of
endometriosis by triggering proinflammatory cytokines and
angiogenic growth factors. J Immunol. 195:2591–2600.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Antsiferova YS, Sotnikova NY, Posiseeva LV
and Shor AL: Changes in the T-helper cytokine profile and in
lymphocyte activation at the systemic and local levels in women
with endometriosis. Fertil Steril. 84:1705–1711. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gogacz M, Winkler I, Bojarska-Junak A,
Tabarkiewicz J, Semczuk A, Rechberger T and Adamiak A: Increased
percentage of Th17 cells in peritoneal fluid is associated with
severity of endometriosis. J Reprod Immunol. 117:39–44.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Izumi G, Koga K, Takamura M, Makabe T,
Satake E, Takeuchi A, Taguchi A, Urata Y, Fujii T and Osuga Y:
Involvement of immune cells in the pathogenesis of endometriosis. J
Obstet Gynaecol Res. 44:191–198. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Berbic M, Schulke L, Markham R, Tokushige
N, Russell P and Fraser IS: Macrophage expression in endometrium of
women with and without endometriosis. Hum Reprod. 24:325–332.
2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kim TH, Yoo JY, Choi KC, Shin JH, Leach
RE, Fazleabas AT, Young SL, Lessey BA, Yoon HG and Jeong JW and
Jeong JW: Loss of HDAC3 results in nonreceptive endometrium and
female infertility. Sci Transl Med. 11(eaaf7533)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bozdag G: Recurrence of endometriosis:
Risk factors, mechanisms and biomarkers. Womens Health (Lond).
11:693–699. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gheorghisan-Galateanu AA and Gheorghiu ML:
Hormonal therapy in women of reproductive age with endometriosis:
An update. Acta Endocrinol (Buchar). 15:276–281. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Karkhanis V, Hu YJ, Baiocchi RA, Imbalzano
AN and Sif S: Versatility of PRMT5-induced methylation in growth
control and development. Trends Biochem Sci. 36:633–641.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bandyopadhyay S, Harris DP, Adams GN,
Lause GE, McHugh A, Tillmaand EG, Money A, Willard B, Fox PL and
Dicorleto PE: HOXA9 methylation by PRMT5 is essential for
endothelial cell expression of leukocyte adhesion molecules. Mol
Cell Biol. 32:1202–1213. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Webb LM, Amici SA, Jablonski KA,
Savardekar H, Panfil AR, Li L, Zhou W, Peine K, Karkhanis V,
Bachelder EM, et al: PRMT5-selective inhibitors suppress
inflammatory T cell responses and experimental autoimmune
encephalomyelitis. J Immunol. 198:1439–1451. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zheng Y, Huang L, Ge W, Yang M, Ma Y, Xie
G, Wang W, Bian B, Li L, Nie H and Shen L: Protein arginine
methyltransferase 5 inhibition upregulates Foxp3(+) regulatory T
cells frequency and function during the ulcerative colitis. Front
Immunol. 8(596)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bian X, Li B, Yang J, Ma K, Sun M, Zhang C
and Fu X: Regenerative and protective effects of dMSC-sEVs on
high-glucose-induced senescent fibroblasts by suppressing RAGE
pathway and activating Smad pathway. Stem Cell Res Ther.
11(166)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Johnson NP, Hummelshoj L, Adamson GD,
Keckstein J, Taylor HS, Abrao MS, Bush D, Kiesel L, Tamimi R,
Sharpe-Timms KL, et al: World endometriosis society consensus on
the classification of endometriosis. Hum Reprod. 32:315–324.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fischer AH, Jacobson KA, Rose J and Zeller
R: Hematoxylin and eosin staining of tissue and cell sections. CSH
Protoc. 2008(pdb.prot4986)2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xie Q, He H, Wu YH, Zou LJ, She XL, Xia XM
and Wu XQ: Eutopic endometrium from patients with endometriosis
modulates the expression of CD36 and SIRP-α in peritoneal
macrophages. J Obstet Gynaecol Res. 45:1045–1057. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu XQ, Fang XL, Lin QH, Huang FY and Xia
XM: VEGF production and its receptor expression of MPhis in
peritoneal fluid. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 19:462–465.
2003.PubMed/NCBI(In Chinese).
|
|
21
|
McLaren J, Prentice A, Charnock-Jones DS,
Millican SA, Müller KH, Sharkey AM and Smith SK: Vascular
endothelial growth factor is produced by peritoneal fluid
macrophages in endometriosis and is regulated by ovarian steroids.
J Clin Invest. 98:482–489. 1996.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dasgupta S, Bhattacharya-Chatterjee M,
O'Malley BW Jr and Chatterjee SK: Inhibition of NK cell activity
through TGF-beta 1 by down-regulation of NKG2D in a murine model of
head and neck cancer. J Immunol. 175:5541–5550. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen D, Zeng S, Huang M, Xu H, Liang L and
Yang X: Role of protein arginine methyltransferase 5 in
inflammation and migration of fibroblast-like synoviocytes in
rheumatoid arthritis. J Cell Mol Med. 21:781–790. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li S, Fu X, Wu T, Yang L, Hu C and Wu R:
Role of interleukin-6 and its receptor in endometriosis. Med Sci
Monit. 23:3801–3807. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ulukus M and Arici A: Immunology of
endometriosis. Minerva Ginecol. 57:237–248. 2005.PubMed/NCBI
|
|
27
|
Haber E, Danenberg HD, Koroukhov N, Ron-El
R, Golomb G and Schachter M: Peritoneal macrophage depletion by
liposomal bisphosphonate attenuates endometriosis in the rat model.
Hum Reprod. 24:398–407. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu G and Yang H: Modulation of macrophage
activation and programming in immunity. J Cell Physiol.
228:502–512. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li MZ, Wu YH, Ali M, Wu XQ and Nie MF:
Endometrial stromal cells treated by tumor necrosis factor-α
stimulate macrophages polarized toward M2 via interleukin-6 and
monocyte chemoattractant protein-1. J Obstet Gynaecol Res.
46:293–301. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Doucet M, Jayaraman S, Swenson E, Tusing
B, Weber KL and Kominsky SL: CCL20/CCR6 signaling regulates bone
mass accrual in mice. J Bone Miner Res. 31:1381–1390.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fan Z, Kong X, Xia J, Wu X, Li H, Xu H,
Fang M and Xu Y: The arginine methyltransferase PRMT5 regulates
CIITA-dependent MHC II transcription. Biochim Biophys Acta.
1859:687–696. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ding Q, Chen J, Wei X, Sun W, Mai J, Yang
Y and Xu Y: RAFTsomes containing epitope-MHC-II complexes mediated
CD4+ T cell activation and antigen-specific immune
responses. Pharm Res. 30:60–69. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
González-Ramos R, Defrère S and Devoto L:
Nuclear factor-kappaB: A main regulator of inflammation and cell
survival in endometriosis pathophysiology. Fertil Steril.
98:520–528. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wei H, Wang B, Miyagi M, She Y, Gopalan B,
Huang DB, Ghosh G, Stark GR and Lu T: PRMT5 dimethylates R30 of the
p65 subunit to activate NF-κB. Proc Natl Acad Sci USA.
110:13516–13521. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chan-Penebre E, Kuplast KG, Majer CR,
Boriack-Sjodin PA, Wigle TJ, Johnston LD, Rioux N, Munchhof MJ, Jin
L, Jacques SL, et al: A selective inhibitor of PRMT5 with in vivo
and in vitro potency in MCL models. Nat Chem Biol. 11:432–437.
2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Harris DP, Bandyopadhyay S, Maxwell TJ,
Willard B and DiCorleto PE: Tumor necrosis factor (TNF)-α induction
of CXCL10 in endothelial cells requires protein arginine
methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65
methylation. J Biol Chem. 289:15328–15339. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Poli-Neto OB, Meola J, Rosa-E-Silva JC and
Tiezzi D: Transcriptome meta-analysis reveals differences of immune
profile between eutopic endometrium from stage I-II and III-IV
endometriosis independently of hormonal milieu. Sci Rep.
10(313)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Nagarsheth N, Wicha MS and Zou W:
Chemokines in the cancer microenvironment and their relevance in
cancer immunotherapy. Nat Rev Immunol. 17:559–572. 2017.PubMed/NCBI View Article : Google Scholar
|
